AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Epstein-Barr virus latent membrane protein can be therapeutic target.

Drug Week

| December 27, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 DEC 27 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified a novel method for treating latent Epstein-Barr virus infection.

"Epstein-Barr virus (EBV) is a human herpesvirus that establishes a lifelong latent infection in the majority of the human population," explained Lori Cooper and colleagues at Northwestern University Medical School in Chicago. "In normal individuals, latent infection with EBV typically poses no health risk, but upon immunosuppression, either following organ transplantation or HIV infection, malignancies and lymphoproliferative diseases can result."

EBV's latent membrane protein 2A (LMP2A) represents a novel therapeutic target, Cooper and coauthors found.

The researchers evaluated the antiviral efficacy of agents that block the function of kinases whose activity is affected by LMP2A. These include the Src family of protein tyrosine kinases, the Syk and Btk protein tyrosin kinases, and phosphatidylinositol 3-kinase, according to the report.

The Syk tyrosine kinase inhibitor piceatannol had a significant effect on cultured EBV-infected B cells, study data showed. Piceatannol treatment had no effect on uninfected B cells.

None of the other ...

Related articles from newspapers, magazines, journals, and more
Epstein-Barr virus latent membrane protein can be therapeutic target.
Newspaper article from: Proteomics Weekly December 23, 2002 700+ words
...Epstein-Barr virus (EBV) is...represents a novel therapeutic target, Cooper...signalosome - a therapeutic target for Epstein-Barr virus latency and...Epstein-Barr virus (EBV) latent...may be a therapeutic target * The Syk...
MacroGenics Licenses Therapeutic Target for Epstein-Barr Virus; Antibody...
Press release article from: PR Newswire May 14, 2002 700+ words
ROCKVILLE, Md. -- MacroGenics, Inc. announced the licensing of a therapeutic target induced by Epstein-Barr virus (EBV), the cause of infectious mononucleosis ("mono") and certain lymphomas, from EBVax...
Candidate vaccines for Epstein-Barr virus.(Editorial)
Magazine article from: British Medical Journal Moss, D.J. Suhrbier, A. Elliott, S.L. August 15, 1998 700+ words
...immune variables that control Epstein-Barr virus infection, detailed planning can now...consequences of primary infection with Epstein-Barr virus (infectious mononucleosis and post...infection. It might be argued that Epstein-Barr virus has evolved to generate an asymptomatic...
Association between Epstein-Barr virus and classic Hodgkin lymphoma in Jordan:...
Magazine article from: Southern Medical Journal Vasef, Mohammad A. Ubaidat, Manaf A. Khalidi, Hasan S. Almasri, Nidal M. Al-Abbadi, Mousa Annab, Hassan Z. March 1, 2004 700+ words
...Abstract: An association between Epstein-Barr virus and Hodgkin lymphoma has been shown in...The reported incidence of Epstein-Barr virus in Hodgkin lymphoma varies significantly...hybridization for detection of Epstein-Barr virus-encoded RNA and immunohistochemistry...
A versatile virus: Epstein-Barr virus displays a few new malignant tricks....
Magazine article from: Science News Fackelmann, Kathy A. February 18, 1995 700+ words
...unpublished report linking the Epstein-Barr virus to this same cancer, so they decided...striking and unexpected." Epstein-Barr virus belongs to the herpesvirus family. About...contracted this bug in childhood, Epstein-Barr virus can cause the high fevers and malaise...
Viral survivor: new studies suggest how Epstein-Barr virus infects and persists.
Magazine article from: Science News Travis, John August 3, 2002 700+ words
...try to stop him. Think of Epstein-Barr virus as a microscopic sleeper agent. Usually...under certain circumstances, Epstein-Barr virus is far from benign. When roused from...2/18/95, p. 104). Epstein-Barr virus appears to cause at least two malignancies...
Research on Epstein-Barr virus reported by scientists at University of...
Newspaper article from: Virus Weekly July 29, 2008 700+ words
...among human cytomegalovirus, Epstein-Barr virus and six putative periodontopathic bacteria...United States report (see also Epstein-Barr Virus). "Fifteen periodontitis patients...of human cytomegalovirus, Epstein-Barr virus, Porphyromonas gingivalis, Tannerella...
Establishing a link. (between Epstein-Barr virus and cancer)
Magazine article from: Science News Silberner, Joanne June 1, 1985 700+ words
...provided a clear link between Epstein-Barr virus and cancer. It is likely that more was...mononucleosis, a condition caused by Epstein-Barr virus. As his health slipped away, doctors...a proliferation induced by Epstein-Barr virus. The autopsy revealed small, whitish...
Epstein-Barr Virus Might Kick-Start Multiple Sclerosis.
News wire article from: AScribe Health News Service May 1, 2006 700+ words
...immune cells that overreact to Epstein-Barr virus. The virus, which causes mononucleosis...to trigger the disease, and Epstein-Barr virus is one of the leading candidate triggers...University in New York. "Epstein-Barr virus does not cause MS, but the immune response...
Acute Epstein-Barr virus infection causing bilateral conjunctival...
Magazine article from: Southern Medical Journal Kanafani, Zeina A. Bashur, Ziad Kanj, Souha S. March 1, 2005 700+ words
...ocular manifestations of acute Epstein-Barr virus infection are protean. Conjunctival...hemorrhages in the setting of acute Epstein-Barr virus infection. Key Words: conjunctival hemorrhage, Epstein-Barr virus, eye ********** Epstein...
For more facts and information, see all results

Source: HighBeam Research, Epstein-Barr virus latent membrane protein can be therapeutic target.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA